发明名称 LIQUID PHARMACEUTICAL COMPOSITION OF CONJUGATED ERYTHROPOIETIN
摘要 A liquid pharmaceutical composition having a conjugated erythropoietin, buffer, sugar, tonicity modifier and amino acid as an aggregation inhibitor. The liquid pharmaceutical composition provides a stable pharmaceutical composition which encompasses conjugated erythropoietin, acetate buffer, sucrose, arginine and sodium chloride which is maintained at a pH of about 4.9 to 5.3.
申请公布号 US2017112901(A1) 申请公布日期 2017.04.27
申请号 US201515300504 申请日期 2015.02.27
申请人 Intas Pharmaceuticals Ltd. 发明人 CHHATBAR Chandresh;PANDEY Vijaykant;CHAUHAN Nildip
分类号 A61K38/18;A61K47/26;A61K47/18;A61K47/02;A61K47/12 主分类号 A61K38/18
代理机构 代理人
主权项 1. A liquid pharmaceutical formulation comprising: a conjugated EPO, and a buffer which is selected from the group consisiting of acetate, arginine, histidine, succinate or a combination thereof, an aggregation inhibitor, sodium chloride as tonicity modifier and sucrose as stabilizer wherein the pH of the formulation is between 4.9 to 5.3.
地址 Ahmedabad IN